Who
GordonMD Global Investments LP
10% owner
Company insider
Files Form 4 as: 10% owner, Pyxis Oncology.
In numbers
- Trades disclosed
- 3
- Buys
- 1
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 1 Oct 2026
- Last trade
- 1 Oct 2026
- Last filed
- 9 Oct 2026
Companies traded
Activity over time
1 Sep – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 9 Oct 2026 | PYXS Pyxis Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code P | —7,172,000 | filing |
| 1 Oct 2026filed 2 Oct 2026 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Bought | —5,517,000 | filing |
| 1 Oct 2026filed 2 Oct 2026 | PYXS Pyxis Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code P | —7,546,766 | filing |
News
Critical Analysis: Pyxis Oncology (NASDAQ:PYXS) versus Inovio Pharmaceuticals (NASDAQ:INO)PYXS · themarketsdaily.com · 8 Oct 2026
0 headlines in the last 90 days name GordonMD Global Investments LP; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.